PortfoliosLab logoPortfoliosLab logo
NKE vs. AMGN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NKE vs. AMGN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NIKE, Inc. (NKE) and Amgen Inc. (AMGN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NKE achieves a -28.37% return, which is significantly lower than AMGN's 10.10% return. Over the past 10 years, NKE has underperformed AMGN with an annualized return of -0.48%, while AMGN has yielded a comparatively higher 12.08% annualized return.


NKE

1D
-2.24%
1M
7.07%
YTD
-28.37%
6M
-32.37%
1Y
-26.49%
3Y*
-23.49%
5Y*
-18.04%
10Y*
-0.48%

AMGN

1D
0.32%
1M
6.37%
YTD
10.10%
6M
13.41%
1Y
23.07%
3Y*
20.61%
5Y*
11.36%
10Y*
12.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NKE vs. AMGN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NKE
NIKE, Inc.
-28.37%-13.83%-29.11%-6.01%-29.04%18.70%40.97%38.09%19.87%24.70%
AMGN
Amgen Inc.
10.10%29.67%-6.77%13.46%20.43%0.87%-1.99%27.60%15.23%22.27%

Correlation

The correlation between NKE and AMGN is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Sep 7, 1984

0.22

Fundamentals

Market Cap

NKE:

$66.51B

AMGN:

$193.23B

EPS

NKE:

$1.52

AMGN:

$14.38

PE Ratio

NKE:

29.55

AMGN:

24.70

PS Ratio

NKE:

1.43

AMGN:

5.17

PB Ratio

NKE:

4.72

AMGN:

21.03

Total Revenue (TTM)

NKE:

$46.52B

AMGN:

$37.24B

Gross Profit (TTM)

NKE:

$18.99B

AMGN:

$26.61B

EBITDA (TTM)

NKE:

$3.33B

AMGN:

$17.27B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NKE vs. AMGN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NKE
NKE Risk / Return Rank: 1717
Overall Rank
NKE Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
NKE Sortino Ratio Rank: 1515
Sortino Ratio Rank
NKE Omega Ratio Rank: 1515
Omega Ratio Rank
NKE Calmar Ratio Rank: 2222
Calmar Ratio Rank
NKE Martin Ratio Rank: 2020
Martin Ratio Rank

AMGN
AMGN Risk / Return Rank: 6868
Overall Rank
AMGN Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
AMGN Sortino Ratio Rank: 6666
Sortino Ratio Rank
AMGN Omega Ratio Rank: 6464
Omega Ratio Rank
AMGN Calmar Ratio Rank: 7070
Calmar Ratio Rank
AMGN Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NKE vs. AMGN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NIKE, Inc. (NKE) and Amgen Inc. (AMGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NKEAMGNDifference
Sharpe ratioReturn per unit of total volatility

-1.53

Sortino ratioReturn per unit of downside risk

-2.26

Omega ratioGain probability vs. loss probability

0.89

1.17

-0.28

Calmar ratioReturn relative to maximum drawdown

-0.58

1.40

-1.97

Martin ratioReturn relative to average drawdown

-1.09

3.22

-4.31

NKE vs. AMGN - Sharpe Ratio Comparison

The current NKE Sharpe Ratio is -0.69, which is lower than the AMGN Sharpe Ratio of 0.84. The chart below compares the historical Sharpe Ratios of NKE and AMGN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NKE vs. AMGN - Drawdown Comparison

The maximum NKE drawdown since its inception was -75.19%, which is greater than AMGN's maximum drawdown of -63.48%. Use the drawdown chart below to compare losses from any high point for NKE and AMGN.


Loading charts...

Drawdown Indicators


NKEAMGNDifference

Max Drawdown

Largest peak-to-trough decline

-75.19%

-63.48%

-11.71%

Max Drawdown (1Y)

Largest decline over 1 year

-46.18%

-16.57%

-29.61%

Max Drawdown (3Y)

Largest decline over 3 years

-64.21%

-22.74%

-41.47%

Max Drawdown (5Y)

Largest decline over 5 years

-74.64%

-24.86%

-49.78%

Max Drawdown (10Y)

Largest decline over 10 years

-74.64%

-24.86%

-49.78%

Current Drawdown

Current decline from peak

-72.55%

-7.80%

-64.75%

Average Drawdown

Average peak-to-trough decline

-20.93%

-16.77%

-4.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.38%

7.19%

+17.19%

Volatility

NKE vs. AMGN - Volatility Comparison

NIKE, Inc. (NKE) has a higher volatility of 10.43% compared to Amgen Inc. (AMGN) at 7.92%. This indicates that NKE's price experiences larger fluctuations and is considered to be riskier than AMGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NKEAMGNDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.43%

7.92%

+2.51%

Volatility (6M)

Calculated over the trailing 6-month period

29.43%

19.22%

+10.21%

Volatility (1Y)

Calculated over the trailing 1-year period

38.48%

27.79%

+10.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.91%

23.97%

+11.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.29%

24.86%

+7.43%

Dividends

NKE vs. AMGN - Dividend Comparison

NKE's dividend yield for the trailing twelve months is around 3.63%, more than AMGN's 2.76% yield.


PositionTTM20252024202320222021202020192018201720162015
AMGN
Amgen Inc.
2.76%2.91%3.45%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%
NKE
NIKE, Inc.
3.63%2.53%2.00%1.28%1.07%0.68%0.71%0.89%1.11%1.18%1.30%0.93%

Financials

NKE vs. AMGN - Financials Comparison

This section allows you to compare key financial metrics between NIKE, Inc. and Amgen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


6.00B8.00B10.00B12.00B14.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
11.28B
8.62B
(NKE) Total Revenue
(AMGN) Total Revenue
Values in USD except per share items

NKE vs. AMGN - Profitability Comparison

The chart below illustrates the profitability comparison between NIKE, Inc. and Amgen Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
40.2%
68.2%
Portfolio components
NKE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NIKE, Inc. reported a gross profit of 4.53B and revenue of 11.28B. Therefore, the gross margin over that period was 40.2%.

AMGN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amgen Inc. reported a gross profit of 5.87B and revenue of 8.62B. Therefore, the gross margin over that period was 68.2%.

NKE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NIKE, Inc. reported an operating income of 553.00M and revenue of 11.28B, resulting in an operating margin of 4.9%.

AMGN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amgen Inc. reported an operating income of 2.67B and revenue of 8.62B, resulting in an operating margin of 30.9%.

NKE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NIKE, Inc. reported a net income of 520.00M and revenue of 11.28B, resulting in a net margin of 4.6%.

AMGN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amgen Inc. reported a net income of 1.82B and revenue of 8.62B, resulting in a net margin of 21.1%.


Frequently Asked Questions


NKE and AMGN have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NKE has higher volatility (10.43%) compared to AMGN (7.92%). In terms of maximum drawdown, NKE dropped -75.19% vs AMGN's -63.48%.

AMGN currently has the higher Sharpe Ratio (0.84 vs -0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NKE and AMGN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer